{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:44:47Z","timestamp":1790729087571,"version":"4.1.0"},"reference-count":63,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,3,1]]},"abstract":"<jats:title>This Clinical Report was revised. See https:\/\/doi.org\/10.1542\/peds.2024-066842.<\/jats:title>\n               <jats:p>Sickle cell disease (SCD) is a group of complex genetic disorders with multisystem manifestations. This statement provides pediatricians in primary care and subspecialty practice with an overview of the genetics, diagnosis, clinical manifestations, and treatment of SCD. Specialized comprehensive medical care decreases morbidity and mortality during childhood. The provision of comprehensive care is a time-intensive endeavor that includes ongoing patient and family education, periodic comprehensive evaluations and other disease-specific health maintenance services, psychosocial care, and genetic counseling. Timely and appropriate treatment of acute illness is critical, because life-threatening complications develop rapidly. It is essential that every child with SCD receive comprehensive care that is coordinated through a medical home with appropriate expertise.<\/jats:p>","DOI":"10.1542\/peds.109.3.526","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:17:55Z","timestamp":1092442675000},"page":"526-535","source":"Crossref","is-referenced-by-count":163,"title":["Health Supervision for Children with Sickle Cell Disease"],"prefix":"10.1542","volume":"109","author":[{"name":"Section on Hematology\/Oncology and Committee on Genetics","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2002,3,1]]},"reference":[{"key":"2024081912514555700_R1","doi-asserted-by":"crossref","unstructured":"Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: effect on mortality. Pediatrics.1988;81:749\u2013755","DOI":"10.1542\/peds.81.6.749"},{"key":"2024081912514555700_R2","unstructured":"Vichinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol.1991;28:220\u2013226"},{"key":"2024081912514555700_R3","doi-asserted-by":"crossref","unstructured":"Wong WY, Powars DR, Chan L, Hiti A, Johnson C, Overturf G. Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience. Am J Hematol.1992;39:176\u2013182","DOI":"10.1002\/ajh.2830390305"},{"key":"2024081912514555700_R4","doi-asserted-by":"crossref","unstructured":"Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ.1995;311:1600\u20131602","DOI":"10.1136\/bmj.311.7020.1600"},{"key":"2024081912514555700_R5","doi-asserted-by":"crossref","unstructured":"Lane PA. Sickle cell disease. Pediatr Clin North Am.1996;43:639\u2013664","DOI":"10.1016\/S0031-3955(05)70426-0"},{"key":"2024081912514555700_R6","unstructured":"National Heart, Lung, and Blood Institute. Management and Therapy of Sickle Cell Disease. 4th ed. Bethesda, MD: National Institutes of Health;2002. In press"},{"key":"2024081912514555700_R7","unstructured":"Embury SH, Hebbel RP, Mohandas W, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press;1994"},{"key":"2024081912514555700_R8","unstructured":"Sergeant GR. Sickle Cell Disease. 2nd ed. Oxford, England: Oxford University Press;1992"},{"key":"2024081912514555700_R9","unstructured":"Sickle Cell Disease Guideline Panel. Sickle Cell Disease: Screening, Diagnosis, Management, and Counseling in Newborns and Infants. Rockville, MD: Agency for Health Care Policy and Research, US Department of Health and Human Services;1993. AHCPR Publ. No. 93-0562"},{"key":"2024081912514555700_R10","doi-asserted-by":"crossref","unstructured":"Charache S, Johnson CS, eds. Sickle cell disease. Hematol Oncol Clin North Am.1996;10:1221\u20131382","DOI":"10.1016\/S0889-8588(05)70408-1"},{"key":"2024081912514555700_R11","unstructured":"Lane PA, Buchanan GR, Hutter JJ, et al. Sickle Cell Disease in Children and Adolescents: Diagnosis, Guidelines for Comprehensive Care, and Protocols for Management of Acute and Chronic Complications. Denver, CO: Mountain States Genetics Network and Texas Genetics Network;2000"},{"key":"2024081912514555700_R12","unstructured":"The Council of Regional Networks for Genetics Services (CORN). National Newborn Screening Report\u20141992. New York, NY: The Council of Regional Networks for Genetic Services;1995"},{"key":"2024081912514555700_R13","doi-asserted-by":"crossref","unstructured":"Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood.1995;86:776\u2013783","DOI":"10.1182\/blood.V86.2.776.bloodjournal862776"},{"key":"2024081912514555700_R14","doi-asserted-by":"crossref","unstructured":"Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med.1994;330:1639\u20131644","DOI":"10.1056\/NEJM199406093302303"},{"key":"2024081912514555700_R15","doi-asserted-by":"crossref","unstructured":"Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Eng J Med.2000;342:83\u201389","DOI":"10.1056\/NEJM200001133420203"},{"key":"2024081912514555700_R16","doi-asserted-by":"crossref","unstructured":"Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease: rates and risk factors. N Engl J Med.1991;325:11\u201316","DOI":"10.1056\/NEJM199107043250103"},{"key":"2024081912514555700_R17","doi-asserted-by":"crossref","unstructured":"Newborn Screening Task Force. Serving, the family from birth to the medical home. Newborn screening: a blueprint for the future\u2014a call for a national agenda on state newborn screening programs. Pediatrics.2000;106:383\u2013422","DOI":"10.1542\/peds.106.S2.389"},{"key":"2024081912514555700_R18","doi-asserted-by":"crossref","unstructured":"Pass KA, Lane PA, Fernhoff PM, et al. US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. J Pediatr.2000;37(suppl):S1\u2013S46","DOI":"10.1067\/mpd.2000.109437"},{"key":"2024081912514555700_R19","doi-asserted-by":"crossref","unstructured":"Reed W, Lane PA, Lorey F, et al. Sickle-cell disease not identified by newborn screening because of prior transfusion. J Pediatr.2000;136:248\u2013250","DOI":"10.1016\/S0022-3476(00)70110-7"},{"key":"2024081912514555700_R20","unstructured":"American Academy of Pediatrics, Committee on Practice and Ambulatory Medicine. Recommendations for preventive pediatric health care. Pediatrics.1995;96:373\u2013374"},{"key":"2024081912514555700_R21","doi-asserted-by":"crossref","unstructured":"Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med.1986;314:1593\u20131599","DOI":"10.1056\/NEJM198606193142501"},{"key":"2024081912514555700_R22","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases. Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics.2000;106:362\u2013366","DOI":"10.1542\/peds.106.2.362"},{"key":"2024081912514555700_R23","doi-asserted-by":"crossref","unstructured":"Falletta JM, Woods GM, Verter JI, et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. J Pediatr.1995;127:685\u2013690","DOI":"10.1016\/S0022-3476(95)70154-0"},{"key":"2024081912514555700_R24","doi-asserted-by":"crossref","unstructured":"Rogers ZR, Buchanan GR. Bacteremia in children with sickle hemoglobin C disease and sickle beta+-thalassemia: is prophylactic penicillin necessary?J Pediatr.1995;127:348\u2013354","DOI":"10.1016\/S0022-3476(95)70062-5"},{"key":"2024081912514555700_R25","doi-asserted-by":"crossref","unstructured":"Rodriquez-Cortes HM, Griener JC, Hyland K, et al. Plasma homocysteine levels and folate status in children with sickle cell anemia. J Pediatr Hematol Oncol.1999;21:219\u2013223","DOI":"10.1097\/00043426-199905000-00010"},{"key":"2024081912514555700_R26","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases. Recommended childhood immunization schedule\u2014United States, 2002. Pediatrics.2002;109:162\u2013164","DOI":"10.1542\/peds.109.1.162"},{"key":"2024081912514555700_R27","doi-asserted-by":"crossref","unstructured":"Overturf GD and American Academy of Pediatrics, Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics.2000;106:367\u2013376","DOI":"10.1542\/peds.106.2.367"},{"key":"2024081912514555700_R28","unstructured":"American Academy of Pediatrics. 2000 Red Book: Report of the Committee on Infectious Diseases. Pickering LK, ed. 25th ed. Elk Grove Village, IL: American Academy of Pediatrics;2000"},{"key":"2024081912514555700_R29","doi-asserted-by":"crossref","unstructured":"Pegelow CH, Colangelo L, Steinberg M, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med.1997;102:171\u2013177","DOI":"10.1016\/S0002-9343(96)00407-X"},{"key":"2024081912514555700_R30","doi-asserted-by":"crossref","unstructured":"Vichinsky EP, ed. Transfusion-related iron overload in sickle cell anemia. Semin Hematol.2001;38(suppl 1):1\u201384","DOI":"10.1053\/shem.2001.20140"},{"key":"2024081912514555700_R31","doi-asserted-by":"crossref","unstructured":"Pegelow CH, Adams RJ, McKie V, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr.1995;126:896\u2013899","DOI":"10.1016\/S0022-3476(95)70204-0"},{"key":"2024081912514555700_R32","doi-asserted-by":"crossref","unstructured":"Styles LA, Vichinsky E. Effects of a long-term transfusion regimen on sickle cell-related illnesses. J Pediatr.1994;125:909\u2013911","DOI":"10.1016\/S0022-3476(05)82006-2"},{"key":"2024081912514555700_R33","doi-asserted-by":"crossref","unstructured":"Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. Blood.1990;76:1431\u20131437","DOI":"10.1182\/blood.V76.7.1431.bloodjournal7671431"},{"key":"2024081912514555700_R34","doi-asserted-by":"crossref","unstructured":"Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion.1987;27:94\u201398","DOI":"10.1046\/j.1537-2995.1987.27187121485.x"},{"key":"2024081912514555700_R35","doi-asserted-by":"crossref","unstructured":"Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion.1994;34:562\u2013569","DOI":"10.1046\/j.1537-2995.1994.34794330008.x"},{"key":"2024081912514555700_R36","doi-asserted-by":"crossref","unstructured":"Harmatz P, Butensky E, Quirolo K, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood.2000;96:76\u201379","DOI":"10.1182\/blood.V96.1.76"},{"key":"2024081912514555700_R37","doi-asserted-by":"crossref","unstructured":"Kim HC, Dugan NP, Silber JH, et al. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood.1994;83:1136\u20131142","DOI":"10.1182\/blood.V83.4.1136.bloodjournal8341136"},{"key":"2024081912514555700_R38","doi-asserted-by":"crossref","unstructured":"Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med.1995;332:1317\u20131322","DOI":"10.1056\/NEJM199505183322001"},{"key":"2024081912514555700_R39","unstructured":"Kinney TR, Helms RW, O\u2019Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II trial. Blood.1999;94:1550\u20131554"},{"key":"2024081912514555700_R40","unstructured":"Walters MC, Storb R, Patience M, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood.2000;95:1918\u20131924"},{"key":"2024081912514555700_R41","doi-asserted-by":"crossref","unstructured":"Walters MC. Bone marrow transplantation for sickle cell disease: where do we go from here?J Pediatr Hematol Oncol.1999;21:467\u2013474","DOI":"10.1097\/00043426-199911000-00005"},{"key":"2024081912514555700_R42","unstructured":"Vichinsky E, Rust D, Lubin B. A possible disparity between standard of care and delivery of care in sickle cell disease, as assessed from sickle cell centers. Int J Pediatr Hematol Oncol.1999;6:189\u2013197"},{"key":"2024081912514555700_R43","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Pediatric Emergency Medicine. Emergency preparedness for children with special health care needs. Pediatrics.1999;104(4). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/104\/4\/e53","DOI":"10.1542\/peds.104.4.e53"},{"key":"2024081912514555700_R44","doi-asserted-by":"crossref","unstructured":"Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr.1986;109:579\u2013585","DOI":"10.1016\/S0022-3476(86)80216-5"},{"key":"2024081912514555700_R45","doi-asserted-by":"crossref","unstructured":"Wilimas JA, Flynn PM, Harris S, et al. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease. N Engl J Med.1993;329:472\u2013476","DOI":"10.1056\/NEJM199308123290705"},{"key":"2024081912514555700_R46","doi-asserted-by":"crossref","unstructured":"Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med.2000;343:1917\u20131924","DOI":"10.1056\/NEJM200012283432603"},{"key":"2024081912514555700_R47","unstructured":"American Pain Society. Guideline for the Management of Acute and Chronic Pain in Sickle Cell Disease. Glenview, IL: American Pain Society;1999"},{"key":"2024081912514555700_R48","doi-asserted-by":"crossref","unstructured":"Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med.1995;333:699\u2013703","DOI":"10.1056\/NEJM199509143331104"},{"key":"2024081912514555700_R49","doi-asserted-by":"crossref","unstructured":"Quinn CT, Buchanan GR. The acute chest syndrome of sickle cell disease. J Pediatr.1999;135:416\u2013422","DOI":"10.1016\/S0022-3476(99)70162-9"},{"key":"2024081912514555700_R50","doi-asserted-by":"crossref","unstructured":"Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med.2000;342:1855\u20131865","DOI":"10.1056\/NEJM200006223422502"},{"key":"2024081912514555700_R51","doi-asserted-by":"crossref","unstructured":"Hassell KL, Eckman JR, Lane PA. Acute multi-organ failure syndrome. A potentially catastrophic complication of severe sickle cell pain episodes. Am J Med.1994;96:155\u2013162","DOI":"10.1016\/0002-9343(94)90136-8"},{"key":"2024081912514555700_R52","doi-asserted-by":"crossref","unstructured":"Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the preoperative management of sickle cell disease. N Engl J Med.1995;333:206\u2013213","DOI":"10.1056\/NEJM199507273330402"},{"key":"2024081912514555700_R53","doi-asserted-by":"crossref","unstructured":"Emre U, Miller ST, Gutierez M, Steiner P, Rao SP, Rao M. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr.1995;127:901\u2013904","DOI":"10.1016\/S0022-3476(95)70025-0"},{"key":"2024081912514555700_R54","unstructured":"Ohene-Frempong K. Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations. Semin Hematol.1991;28:213\u2013219"},{"key":"2024081912514555700_R55","doi-asserted-by":"crossref","unstructured":"Armstrong FD, Thompson RJ Jr, Wang W, et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics.1996;97:864\u2013870","DOI":"10.1542\/peds.97.6.864"},{"key":"2024081912514555700_R56","doi-asserted-by":"crossref","unstructured":"Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial doppler. Ann Neurol.1997;42:699\u2013704","DOI":"10.1002\/ana.410420505"},{"key":"2024081912514555700_R57","doi-asserted-by":"crossref","unstructured":"Adams RJ, McKie VC, Hsu L, et al. Prevention of first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med.1998;339:5\u201311","DOI":"10.1056\/NEJM199807023390102"},{"key":"2024081912514555700_R58","doi-asserted-by":"crossref","unstructured":"Mantadakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol.1999;21:518\u2013522","DOI":"10.1097\/00043426-199911000-00013"},{"key":"2024081912514555700_R59","doi-asserted-by":"crossref","unstructured":"Mantadakis E, Ewalt DH, Cavender JD, Rogers ZR, Buchanan GR. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood.2000;95:78\u201382","DOI":"10.1182\/blood.V95.1.78"},{"key":"2024081912514555700_R60","doi-asserted-by":"crossref","unstructured":"Koshy M, Burd L, Wallace D, Moawad A, Baron J. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease: a randomized cooperative study. N Engl J Med.1988;319:1447\u20131452","DOI":"10.1056\/NEJM198812013192204"},{"key":"2024081912514555700_R61","doi-asserted-by":"crossref","unstructured":"Smith JA, Espeland M, Bellevue R, Bonds D, Brown AK, Koshy M. Pregnancy in sickle cell disease: experience of the cooperative study of sickle cell disease. Obstet Gynecol.1996;87:199\u2013204","DOI":"10.1016\/0029-7844(95)00367-3"},{"key":"2024081912514555700_R62","unstructured":"Centers for Disease Control and Prevention. Reptile-associated salmonellosis\u2014selected states, 1994\u20131995. MMWR Morb Mortal Wkly Rep.1995;44:347\u2013350"},{"key":"2024081912514555700_R63","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Children With Disabilities and Committee on Adolescence. Transition of care provided for adolescents with special health care needs. Pediatrics.1996;98:1203\u20131206","DOI":"10.1542\/peds.98.6.1203"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/3\/526\/1691719\/pe0302000526.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/3\/526\/1691719\/pe0302000526.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T12:52:25Z","timestamp":1724071945000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/109\/3\/526\/79771\/Health-Supervision-for-Children-with-Sickle-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2002,3,1]]},"published-print":{"date-parts":[[2002,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.109.3.526","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3,1]]}}}